SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17532033
Source:
http://linkedlifedata.com/resource/pubmed/id/17532033
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0014939
,
umls-concept:C0034833
,
umls-concept:C0205210
,
umls-concept:C0439849
,
umls-concept:C0813148
,
umls-concept:C1274040
,
umls-concept:C1512288
,
umls-concept:C2603343
pubmed:issue
2
pubmed:dateCreated
2007-7-30
pubmed:abstractText
The goal of this study was to explore the relationship between the expression of hormone receptors in metastatic endometrial tumors and clinical response to daily tamoxifen citrate and intermittent weekly medroxyprogesterone acetate.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA 27469
,
http://linkedlifedata.com/resource/pubmed/grant/CA 37517
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0365304
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/Medroxyprogesterone Acetate
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone
,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0090-8258
pubmed:author
pubmed-author:FiliaciVirginia JVJ
,
pubmed-author:LeslieKimberly KKK
,
pubmed-author:SinghMeenakshiM
,
pubmed-author:ZainoRichard JRJ
pubmed:issnType
Print
pubmed:volume
106
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
325-33
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17532033-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:17532033-Endometrial Neoplasms
,
pubmed-meshheading:17532033-Estrogen Receptor alpha
,
pubmed-meshheading:17532033-Female
,
pubmed-meshheading:17532033-Humans
,
pubmed-meshheading:17532033-Immunohistochemistry
,
pubmed-meshheading:17532033-Medroxyprogesterone Acetate
,
pubmed-meshheading:17532033-Neoplasm Staging
,
pubmed-meshheading:17532033-Prospective Studies
,
pubmed-meshheading:17532033-Receptors, Progesterone
,
pubmed-meshheading:17532033-Tamoxifen
,
pubmed-meshheading:17532033-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study.
pubmed:affiliation
Department of Pathology, The University of Colorado Health Sciences Center, Denver, CO 80262, United States.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase II
,
Research Support, N.I.H., Extramural